RetinAI vs ArteraAI
A side-by-side comparison built from both listings. Blank cells mean the company has not given that detail; we never guess.
RetinAI compared with ArteraAI
| Detail | 
RetinAI | 
ArteraAI |
|---|
| What it does | AI and data management platform for ophthalmology
| Personalized precision medicine powered by AI for cancer therapy
|
|---|
| Stage | Not given
| Not given
|
|---|
| Founded | Not given
| Not given
|
|---|
| Based in | Not given
| US
|
|---|
| Pricing model | Contact for pricing
| Contact for pricing
|
|---|
| Pricing | Not given
| Not given
|
|---|
| Key features | - CE-marked AI models for AMD, DR, DME, and glaucoma analysis
- Automated OCT data synchronization from devices
- DICOM and proprietary imaging format compatibility
- Cloud-based secure data storage with GDPR and HIPAA compliance
- Automatic anonymization of DICOM images
| - Analyzes digital pathology with no additional tissue staining required
- Rapid results within 1-2 days after specimen receipt
- Validated across diverse populations including African American and non-African American men
- FDA De Novo authorization for prostate cancer risk stratification
- Insurance coverage for Medicare and many commercial plans
- Provides 5 and 10-year distant metastasis risk for breast cancer
- Identifies breast cancer patients who benefit from chemotherapy
- Included in NCCN Clinical Practice Guidelines for Prostate Cancer
|
|---|
| What makes it different | - First-in-class data management platform integrated with AI modules for ophthalmology
- Seamless OCT device integration with automated data sync under 30 seconds
- Enables real-world evidence and research collaboration at scale
| - No additional tissue preparation needed, uses existing H&E slides
- Validated across multiple large randomized phase III clinical trials
- FDA De Novo clearance as Software as a Medical Device
- Financial assistance program to make tests affordable regardless of income
|
|---|
| Community votes | 0 | 0 |
|---|
| DR (Domain Rating by Ahrefs) | 34 ● no change since last check | 57 ● no change since last check |
|---|
| Trust Flow (Majestic) | 13 | 15 |
|---|
| Citation Flow (Majestic) | 31 | 27 |
|---|
| Referring domains (Majestic) | 215 | 285 |
|---|
4 details filled in for both companies.
More alternatives to RetinAI More alternatives to ArteraAI